A new drug that uses the body's immune system to fight metastatic melanoma, called Keytruda, was developed by Merck pharmaceuticals and approved Thursday by US regulators. Also known as pembrolizumab, the drug is the sixth new therapy to be approved against the deadly skin cancer since 2011, the US Food and Drug Administration said. "Keytruda is the first approved drug that blocks a cellular pathway known as PD-1, which restricts the body's immune system ...Friday, 5 September 2014
New Immunotherapy Drug Against Melanoma Approved by US
A new drug that uses the body's immune system to fight metastatic melanoma, called Keytruda, was developed by Merck pharmaceuticals and approved Thursday by US regulators. Also known as pembrolizumab, the drug is the sixth new therapy to be approved against the deadly skin cancer since 2011, the US Food and Drug Administration said. "Keytruda is the first approved drug that blocks a cellular pathway known as PD-1, which restricts the body's immune system ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment